Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06282926 |
Other study ID # |
324811 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
March 2024 |
Est. completion date |
September 2025 |
Study information
Verified date |
February 2024 |
Source |
Guy's and St Thomas' NHS Foundation Trust |
Contact |
R&D office |
Phone |
02071887188 |
Email |
R&D[@]gstt.nhs.uk |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The main objective of this study is to evaluate the reproducibility and accuracy of TTE-3DKBR
in assessing RV volume and EF compared to the reference method of CMR in a group of ACHD
patients with known moderate or severe PR after ToF repair.
As part of the validation study, the reproducibility of the TTE-3DKBR in assessing RV volume
and EF will also be tested in a group of healthy adult volunteers. Additionally, TTE-3DKBR
evaluation will be compared in both groups to the conventional 2D echocardiography
measurements used in routine clinical practice, such as tricuspid annular plane systolic
excursion (TAPSE), tissue Doppler imaging (TDI), fractional area change (FAC), and global
longitudinal strain (GLS).
Another objective of the study is also to evaluate the effects of chronic RV volume overload
with an interval of one-year follow-up using TTE-3DKBR and compare it with the conventional
non-geometric echocardiography measurements, particularly with GLS.
The study will end when the required number of patients have been enrolled and when the last
subject undergoes the research dataset acquisition. The study may be terminated prematurely
if it becomes apparent that the recruitment target cannot be met within the projected
recruitment phase.
Description:
Tetralogy of Fallot (ToF) is a complex pathophysiology characterised by different factors
that affect the right ventricle (RV) performance. Before surgical repair in childhood, the RV
is exposed to pressure load with associated abnormal RV outflow tract (RVOT) hypertrophy and
myocardial damage related to prolonged cyanosis. After surgical repair involving a pulmonary
valve (PV) transannular patch, the RV may experience chronic volume overload due to
significant pulmonary regurgitation (PR). The effects of chronic volume overload often found
in adult congenital heart disease (ACHD) patients frequently result in progressive RV
dilatation with abnormal geometry and RV dysfunction with associated electromechanical
dyssynchrony. All this often leads to re-intervention with PV replacement. In asymptomatic
patients with severe PR, the 2020 European ACHD guidelines recommendation for PV replacement
gives a class 2a recommendation and evidence level C in cases of progressive RV systolic
dysfunction and/or dilatation with a RV indexed end-diastolic volume (EDVi) ≥160 mL/m2,
and/or a RV indexed end-systolic volume (ESVi) ≥80 mL/m2. The guidelines also mentioned gaps
regarding the need for more longitudinal imaging data to optimise time for re-intervention
because the possibility for RV remodelling is, at some point, irreversible.
CMR is widely recognised in the literature as the reference standard imaging technique for
accurately quantifying RV volume and ejection fraction (EF) in the ACHD population. However,
unlike transthoracic echocardiography (TTE), CMR is not the first-line test used in daily
clinical practice.
The echocardiographic requirement of conventional multiple non-geometric (tricuspid annular
plane systolic excursion, tissue Doppler imaging, global longitudinal strain) and geometric
two-dimensional (2D) parameters (fractional area change, three-dimensional volume and EF) for
a more accurate RV size and systolic function assessment is consensual in the literature with
global longitudinal strain (GLS) emerging as a simple and effective tool for the management
of repaired ToF patients. Also, it is known that conventional three-dimensional (3D)
echocardiography systematically underestimates RV volumes and overestimates EF. Therefore,
CMR and conventional 3D echo should not be used interchangeably.
Alternatively, 3D knowledge-based reconstruction derived from 2D echocardiography (TTE-3DKBR)
has shown to be a valuable tool for RV volume and EF assessment that can complement CMR and
maximise the available resources in clinical practice. The literature on TTE-3DKBR in
children and adults with ToF indicates a high correlation with CMR, and its potential for
clinical follow-up in repaired ToF patients may be relevant. However, the recommendations of
the expert consensus documents are also clear that further validation studies are needed
before its implementation in clinical practice.
The current longitudinal study aims to further the role of TTE-3DKBR in evaluating the
effects of chronic RV volume overload in ACHD repaired ToF patients by assessing its
reproducibility and accuracy against CMR and conventional echocardiography measurements,
particularly with standard GLS.